In patients receiving VYEPTI 100 mg or 300 mg every 3 months, the incidence of anti-eptinezumab-jjmr antibody development in Study 1 (up to 56 weeks) was 20.6% (92/447), and 41.3% (38/92) of those patients developed anti
Php find key in multidimensional array
DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? ISTURISA is a drug for the treatment of adults with Cushing’s disease: who cannot have pituitary gland surgery, or After the initial dose of ZEPOSIA 0.23 mg, the greatest mean decrease in HR from baseline (1.2 bpm) occurred at Hour 5 on Day 1, returning to near baseline at Hour 6; Within 6 hours of initiating therapy: Mean supine HR for patients treated with ZEPOSIA did not drop below 66 bpm.
ZEPOSIA® (zeh-poe’-see-ah) (ozanimod) capsules, for oral use Read this Medication Guide before you start taking ZEPOSIA and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking with your healthcare provider about your medical condition or treatment. Filed in March 31 (2016), the ZEPOSIA covers Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical ...